The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease
Open Access
- 23 May 2024
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 143 (21) , 2145-2151
Abstract
Voxelotor is an inhibitor of sickle hemoglobin polymerization that is used to treat sickle cell disease. Although voxelotor has been shown to improve anemia, the clinical benefit on the brain remains to be determined. This study quantified the cerebral hemodynamic effects of voxelotor in children with sickle cell anemia (SCA) using noninvasive diffuse optical spectroscopies. Specifically, frequency-domain near-infrared spectroscopy combined with diffuse correlation spectroscopy were used to noninvasively assess regional oxygen extraction fraction (OEF), cerebral blood volume, and an index of cerebral blood flow (CBFi). Estimates of CBFi were first validated against arterial spin–labeled magnetic resonance imaging (ASL-MRI) in 8 children with SCA aged 8 to 18 years. CBFi was significantly positively correlated with ASL-MRI–measured blood flow (R2 = 0.651; P = .015). Next, a single-center, open-label pilot study was completed in 8 children with SCA aged 4 to 17 years on voxelotor, monitored before treatment initiation and at 4, 8, and 12 weeks (NCT05018728). By 4 weeks, both OEF and CBFi significantly decreased, and these decreases persisted to 12 weeks (both P < .05). Decreases in CBFi were significantly correlated with increases in blood hemoglobin (Hb) concentration (P = .025), whereas the correlation between decreases in OEF and increases in Hb trended toward significance (P = .12). Given that previous work has shown that oxygen extraction and blood flow are elevated in pediatric SCA compared with controls, these results suggest that voxelotor may reduce cerebral hemodynamic impairments. This trial was registered at www.ClinicalTrials.gov as #NCT05018728.Keywords
This publication has 44 references indexed in Scilit:
- Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 yearsPediatric Blood & Cancer, 2022
- Magnetic resonance imaging metrics of oxygen extraction fraction: Contradictions or insight into pathophysiological mechanisms?American Journal of Hematology, 2022
- Cerebral oxygen metabolic stress is increased in children with sickle cell anemia compared to anemic controlsAmerican Journal of Hematology, 2022
- Reduced global cerebral oxygen metabolic rate in sickle cell disease and chronic anemiasAmerican Journal of Hematology, 2021
- Cerebral oxygen metabolism in adults with sickle cell diseaseAmerican Journal of Hematology, 2020
- Differential cerebral hemometabolic responses to blood transfusions in adults and children with sickle cell anemiaJournal of Magnetic Resonance Imaging, 2018
- Diminished cerebral oxygen extraction and metabolic rate in sickle cell disease using T2 relaxation under spin tagging MRIMagnetic Resonance in Medicine, 2017
- Noninvasive Optical Quantification of Cerebral Venous Oxygen Saturation in HumansAcademic Radiology, 2014
- Noninvasive Measurement of Cerebral Blood Flow and Blood Oxygenation Using Near-Infrared and Diffuse Correlation Spectroscopies in Critically Brain-Injured AdultsNeurocritical Care, 2009
- Noninvasive optical measures of CBV, StO2, CBF index, and rCMRO2 in human premature neonates' brains in the first six weeks of lifeHuman Brain Mapping, 2009